Activity value 71afghanistan Buyer,Last transaction date:
2025-04-20
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for new karwan pharma ltd. from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 1 transactions, with a transaction quantity of 3939.48 and a transaction weight of 0.
YearTransactionsQuantityWeight
2024000
202513939.480
Bill of lading data
<
1/12
>
Trade date
2025/04/20
B/L No.
pghe-sb-13546-20-04-2025
Product description
01X20` HD FCL STC 640 BOXES MEDICAL DISPOSABLES - BROMED I.V. CANNULA WITH PORT AND WITH WINGS \CARGO IN TRANSIT TO KABUL AFGHANISTAN VIAKARACHI\
Expand
+View All
Partners
Total 3
RankCompanyTransactionsPerDetail
1advin health care
indiasupplier,they trade on 2017-09-05
1083.33%
>
new karwan pharma ltd. is afghanistan Buyer,
and primarily engages in the import and export business of products such as medicine.
According to the 52wmb.com global trade database, as of 2025-04-20, the company has completed 12 international trades,
with its main trading regions covering india,pakistan,united arab emirates etc.
The core products include HS30049099 etc,
often transported via kabul,port kpt etc,
and its main trading partners are advin health care,saltom medical equipmenttrading,cosmo pharma int. (pvt) limited.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on new karwan pharma ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.